Delivery Order SPE2DR25D3012-SPE2DR26F4D8H
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,044.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. Issued on December 8, 2025, with an ultimate completion date of December 9, 2025, this firm fixed-price delivery order represents a small-value transaction within the federal medical supply procurement process. The award was made without a set-aside designation, indicating competitive selection among qualified vendors. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,517.26 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $1,335.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. The award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. This delivery order represents a non-set-aside, competitively awarded transaction and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,321.59 for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 18, 2025, with completion targeted for December 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under a larger contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,217.64 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This non-competitive, firm fixed-price delivery order, issued on December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 4,...
- The Defense Logistics Agency awarded a $1,135.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a non-set-aside competitive award with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.90 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,097.80 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam 10GM, a pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and was awarded on December 12, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,048.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam (10 gm) on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical and medical supply procurement program. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, valued at $1,190.30. This is a firm fixed-price, non-set-aside contract awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D8HDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,014.70 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This non-competitive delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a small-value pharmaceutical supply transaction. The product will be delivered to the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is structured under a firm fixed price contract type, ensuring cost predictability for the federal government. This award is issued as a child order under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support for military and federal healthcare systems worldwide, enabling the company to deliver a broad range of medications, vaccines, and specialized medical commodities across multiple therapeutic domains. AmerisourceBergen Drug Corp's extensive federal contracting history demonstrates its critical role as a pharmaceutical distributor for Department of Defense medical procurement needs, serving entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/18/25 |